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Introduction. Nigeria is a country saddled with a high tubercu-
losis (TB) and human immunodeficiency virus (HIV) burden but 
the possible combination of these communicable diseases with 
diabetes mellitus (DM) has been overlooked. We undertook to 
determine the burden of HIV and DM in persons with TB by docu-
menting the prevalence rates of these disorders. 
Methods. This is a cross-sectional Study that was conducted 
within 54TB/DOT centers in Lagos State. A total of 3,376 persons 
with TB who were on antiTB drugs were screened for HIV and 
DM using standardized tests. Statistical analysis was performed 
using Students t test and chi square.
Results. The frequency of occurrence of DM in TB and that of 
HIV in TB were comparable (4.8% Vs 3.5%). The Study subjects 
with DM were older, had higher waist circumference measure-
ments and had higher proportions of hypertension compared to 
the subjects without DM. The combination of HIV and DM in 
TB was found in (0.3%). We also noted that DM in TB and HIV 
in TB occurred more frequently in the third and fourth decades 
of life. 
Conclusion. This study demonstrated the potential co existence 
of HIV, DM and Tuberculosis. It is therefore important that these 
two diseases are sought for in patients with TB considering the 
changing epidemiology of these diseases particularly in develop-
ing countries like Nigeria.
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Summary
Introduction
Diabetes mellitus (DM) is one of the four priority Non 
communicable diseases identified by the World Health 
Organisation (WHO) and is assuming epidemic propor-
tions with devastating human, social and economic con-
sequences [1]. DM affects 5-6% of the global population 
and in Nigeria, the estimated prevalence of DM was 2.2% 
as at 1997 with present estimates ranging from 6-8% [2]. 
Human immunodeficiency virus is a blood borne retro-
virus typically transmitted via sexual intercourse, shared 
intravenous drug paraphernalia and via mother to child 
transmission. In Nigeria, the human immunodeficiency 
virus (HIV) prevalence among the general population is 
3.6% with an estimated 3.1 million people affected [3]. 
Tuberculosis is a communicable disease caused by any of 
the several species of Mycobacteria usually Mycobacteria 
tuberculosis or tubercle bacillus. Nigeria is ranked fourth 
among the 22 worst affected countries with tuberculosis 
(TB) in the world and the first in Africa. In Nigeria, Lagos 
State carries 8.4% of the nation’s TB burden and this con-
sistently has been responsible for about 11% of the cases 
of TB registered in Nigeria [4]. 
In sub-Saharan Africa, the HIV epidemic is accelerat-
ing the already massive TB epidemic with a documented 
increase in the incidence of TB from 146 per 100,000 
to 345 per 100,000 in 2003 [5]. The prevalence of HIV 
among TB patients increased from 2.2% in 1991 to 19.1% 
in 2001 and to 25% in 2010 thus underscoring the fact 
that the TB scenario in the country is HIV driven [6]. The 
multiple effects of HIV infection on the natural history 
of TB include an increase in the risk for reactivation of 
latent infection and for exogenous infection [7]. The ex-
isting link between DM and TB is well recognised with 
evidence that DM is not only an important risk factor for 
the acquisition of TB but also that TB might induce glu-
cose intolerance and worsen glycaemic control in people 
with diabetes  [8]. There is a global growing awareness 
and concern on the possible relationship between TB 
and DM thus informing the recent collaboration between 
WHO and the International Union Against Tuberculosis 
and Lung Disease (Union) to the effect of putting together 
a document for the care and control of both diseases [9]. 
In countries with high TB burden like China and India 
the reported prevalence rates of DM and TB are 16% [10] 
and 25-44% [11, 12] respectively. In SubSaharan Africa, 
specifically from Tanzania, the documented prevalence of 
DM in TB is 16.7% [13]. 
There is a growing body of evidence to substantiate the 
claim that some infectious diseases may be potential 
risk factors for some non communicable diseases[14]. 
TB and HIV are communicable diseases of public health 
significance that may be closely associated with the de-
velopment of DM [14]. 
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The objective of this Report is the determination of the 
burden of DM and HIV in persons with established di-
agnoses of pulmonary TB. 
Methods
This was a cross sectional Study carried out in Lagos, 
Nigeria. Lagos State is a cosmopolitan state, located in 
the south Western region of Nigeria and has a population 
of about 20 million people.
Participant Recruitment and Data Collection: Patients with 
confirmed diagnoses of TB and on treatment for TB were 
recruited consecutively from 54 DOT centres during the 
Study period, which was from September 2010 to March 
2012. Consenting patients with pulmonary TB of age ≥ 12 
years and who had commenced anti-TB drugs were en-
rolled into the study. Patients who were pregnant, those 
with features of extrapulmonary TB and those who did not 
give Consent were excluded from the recruitment exercise. 
A diagnosis of TB was made if the patient presented with 
clinical symptoms suggestive of TB and either a positive 
sputum smear on Ziehl Nielsen or radiological indices of 
TB. Diagnosed patients were registered and treated with 
antiTB drugs in accordance with the WHO Guidelines [15]. 
The anti-TB drugs used in the intensive phase being Ri-
fampicin, Isoniazid, Ethambutol and Pyrazinamide and in 
the maintenance phase being Rifampicin and Isoniazid.
Measurement of fasting plasma glucose concentration was 
performed in participants using capillary blood with glu-
cose meters that provide plasma equivalent readings. (The 
Finetest Auto-coding™, Infopia Co., Ltd. Korea). The di-
agnosis of DM was made based on the 1999 World Health 
Organization (WHO) guidelines which state that a fasting 
plasma glucose of ≥ 7 mmol/ is in the diabetic range [16]. 
In Lagos State all TB patients receiving care at the DOT 
facilities are routinely screened for HIV. Blood samples 
were tested for the presence of HIV using Elisa kit (Gene-
screen HIV -1/2) and all reactive samples were confirmed 
with a repeat test (Gene 11 Sanofi, Pasteur, Paris). 
Ethical approval for this study was obtained from the 
Lagos State Ministry of Health which directly oversees 
the DOT centers within the State and informed consent 
was obtained from all study participants.
Results
A total of 3,376 persons with tuberculosis were screened 
for HIV and DM. The males were 1932 and females 
1444 thus making up 57% and 43% respectively of the 
Study population. 
The Mean age of the Study population was 34.9 (12.97) 
years. Males were older than females and this difference was 
statistically significant (35.7(12.7) Vs 33.8(13.1), p = 0.001). 
The majority of the Study subjects had some form of 
education as only 120 (3.5%) were non-literates. Of 
the Study subjects who were literate, the proportion of 
persons with primary, secondary and tertiary education 
were 586(18%), 2101(65%) and 571(17%) respectively.
Sputum smear positivity was noted in 2809 (83%) of 
the subjects. HIV infection was found to be present in 
118(3.5%) of the Study subjects. 
Diabetes mellitus in tuberculosis 
Of the 3,376 TB patients screened, 162 (4.8%) were 
found to have DM. Of these 77 (47.5%) already had a 
previous diagnosis of DM thus about half of the patients 
with DM were newly diagnosed cases. A family history 
of DM was documented in 290 (8.5%) of the Study pop-
ulace and hypertension in 59 persons making up 1.7% 
of the Study populace. Well over half-82%- of persons 
with TB and DM had sputum smear positivity for TB. 
The median age of persons with DM in TB was 40 years.
A comparison between persons with TB and DM and 
those without DM showed that persons with DM were 
older and tended to have hypertension as a co-morbidity. 
These results are shown in Table I.
HIV/DM/TB
The number of TB patients who had HIV coinfection was 
118 thus making up 3.5% of the Study group. Patients 
with TB and HIV were older than those without HIV and 
this difference was statistically significant. 38.2(10.1) Vs 
34.8(13), p = 0.004. Well over half (70%) of persons with 
TB and DM were sputum smear positive for TB. 
DM and HIV were present more commonly in patients 
between 40-60 years of age. The distribution of HIV and 
DM according to age decades is shown in Figure 1. 
The HIV/DM/TB prevalence was 11-(0.3%). Patients 
with DM and HIV were older than those with HIV and 
no DM. A comparison of the clinical parameters of per-
sons with TB/HIV/DM versus those with TB/HIV and 
no DM are shown in Table II. 
Discussion
Nigeria like most developing countries is experienc-
ing an epidemiological transition with the burden of 
Tab. I. Comparison of Sociodemographic parameters between TB patients with dm and TB patients without dm.
Variable DM Non DM p
Age (years) 40.7 (12.8) 34.6 (12.9) 0.0001
Waist circumference 74.5 (9.8) 72.6 (9.1) 0.017
gender (m:F) % 57:43 59:41 0.7
hypertension 12 (7.4%) 47 (1.5%) 0.001
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Non communicable diseases (NCD) like DM poised to 
overwhelm the healthcare system that is already over-
burdened by HIV/AIDS, TB and other communicable 
diseases such as malaria.
The relation between HIV and TB has been long es-
tablished and in Africa, the percentage of persons with 
HIV co-infection has steadily risen in geometric pro-
portions from 4% in 2004 to 68% in 2011 [17]. Sub-
Saharan Africa has borne the brunt of the HIV and TB 
co-epidemic and accounts for 79% of the global burden 
of HIV infection-associated TB cases in 2007 [18]. We 
report the frequency of occurrence of HIV in persons 
with TB to be 3.5% and notably occurring in the fourth 
and fifth decades of life. This is against a background 
median prevalence of HIV of 17% which had earlier 
been documented in Nigerians with TB [19]. The im-
plications of this entwined infections are oft times 
grave as they may result in multidrug and extreme drug 
resistance TB, development of other opportunistic in-
fections and ultimately a reduction in both quality and 
quantity of life. 
Diabetes mellitus is a chronic metabolic disease that is 
of public health significance in developing and devel-
oped countries. In sub- Saharan Africa objective docu-
mentation of the predisposition for persons with TB to 
develop DM was done by Mugusi et al [20] who noted 
that DM tended to occur four times more in persons 
with TB in comparison to persons without TB. The pro-
jected global geometric increase in DM is unfortunately 
bound to occur more in developing countries of which 
an estimated 70% are TB endemic countries [21]. In this 
Report we determined from our screening that 50% of 
the persons with DM were newly diagnosed. Our data 
is comparable to that from Indonesia where 61% of per-
sons with DM with TB were noted to be newly diag-
nosed [22]. The clinical correlates of DM in TB included 
older age and higher mean waist circumference and this 
pattern was also documented in persons with DM and 
HIV compared to those with HIV but no DM. We did 
not classify our DM patients but given the median age 
of 40 years of persons with TB who had DM and the 
clinical correlates we are of the opinion that a large ma-
jority of these persons, have type 2DM. Reports from 
Africa and elsewhere indicate that patients with DM and 
TB are usually older and have higher body mass indices 
than TB patients without DM [21]. From the foregoing 
it is pertinent to note that the documented clinical cor-
relates in our Report are essentially known risk factors 
for the development of type 2 DM.It is instructive to 
note that DM was also documented in persons who were 
less than 20 years of age. Sputum smear positivity in 
patients with TB and DM was high and same scenario 
obtained for persons with TB and HIV. The association 
of DM with particularly for smear positive cases of TB 
has been reported in Indian populations with TB [11]. 
The importance of this finding though unclear may be 
related to delayed sputum conversion which has been 
reported [22] as a feature of persons with TB and con-
comitant DM. 
Screening for hypertension though was not a stated ob-
jective of this Report, we undertook to screen for hy-
pertension. The reason for this is because hypertension 
is a co-morbidity that is oft reported in Nigerians with 
DM – a recent Nigerian Report found that as many as 
half of persons with DM also have hypertension  [23]. 
The prevalence of hypertension in our Study populace is 
1.7% but that in the subjects with DM was 7.4%.
Although the combination of DM and HIV in persons 
with TB was less than one percent, the implication of 
these comorbidities may translate into increased mor-
bidity and mortality. In resource poor settings like Ni-
geria with high burden of TB, opportunistic screening 
for DM should be a priority. We have shown that the 
combination of DM and TB is comparable to that of HIV 
and DM but unfortunately DM often goes undiagnosed 
in persons with TB. 
The impact of DM in TB has been found to portend poor 
treatment outcome which could be in the form of drug 
resistance, relapse of TB and death. The presence of TB 
Fig. 1. distribution of the proportions of TB patients with dm 
and hIv. 
Series 1: TB patients with dm, Series 2: TB patients with hIv infection. 
Tab. II. Comparison of the clinical parameters of persons with TB/hIv/dm versus those with TB/hIv and no dm. 
Variable DM/HIV Non DM/HIV p
Age (years) 42.6 (13.2) 34.9 (12.9) 0.04
Waist circumference 80 (12.8) 72.7 (9.1) 0.009
gender (m:F) % 6:5 59:41 0.7
hypertension 2 (18.2%) 3 (2.5%) 0.001
Smear positivity 9 (72.7%) (82.6%) 0.3
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in persons with DM may lead to poor glycaemic control.
Nigeria is facing a dual burden of communicable and 
NCDs. The magnitude of DM in TB and HIV and DM 
in TB is not yet known. 
Conclusion: The dual burden of DM and HIV in persons 
with TB is of moderate magnitude. Given that the DM/
TB combination is comparable to that of HIV/TB, we 
recommend that opportunistic screening for DM be of-
fered to persons with TB. 
Acknowledgement 
I wish to acknowledge the Staff of Structured Healthcare 
Initiatives and Staff of the DOT centres in which these 
TB patients were recruited for the Study. I also acknowl-
edge the World Diabetes Foundation who sponsored this 
work.
References
[1] Zimmet P, Shaw J, Alberti KG. Preventing Type 2 Diabetes and 
the Dysmorphic syndrome in the real world: a realistic view. 
Diabet Med 2003;20:693-702.
[2] Akinkugbe OO, Akinyanju OO. Final Report-national Survey 
on non-communicable diseases in Nigeria. Lagos: Federal Min-
istry of Health 1997, pp. 65-8.
[3] www.unaids.org. HIV and AIDs Estimates, Nigeria 
[4] Global Tuberculosis Report, 2012. Geneva: World Health Or-
ganization 2012.
[5] WHO. Global tuberculosis control: surveillance, planning, fi-
nancing. WHO report 2005. Geneva: World Health Organisa-
tion 2005.
[6] Nigeria Tuberculosis Fact Sheet. Photos.state.gov.libraries/Ni-
geria/487468/pdfs/January Tuberculosis Fact Sheets.pdf. 
[7] DeReimer K. Quantitative impact of human immunodeficiency 
virus infection on tuberculosis dynamics. Am J Respir Crit Care 
Med 2007;176:936. 
[8] Dooley KE, Chaisson RE. Tuberculosis and diabetes mel-
litus: convergence of two epidemics. Lancet Infect Dis 
2009;9:737-46.
[9] Stop TB Initiative (World Health Organization); World Health 
Organization, Department of Chronic Diseases and Health Pro-
motion; International Union against Tuberculosis and Lung Dis-
ease. Collaborative framework for care and control of tuberculo-
sis and diabetes. Geneva: World Health Organization 2011. 
[10] Li L, Lin Y, Mi F, et al. Screening of patients with tubercu-
losis for diabetes mellitus in China. Trop Med Int Health 
2012;17:1294-301.
[11] Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Preva-
lence of diabetes and pre-diabetes and associated risk factors 
among tuberculosis patients in India. PLoS One 2012;7:e41367.
[12] Balakrishnan S, Vijayan S, Nair S, et al. High diabetes preva-
lence among tuberculosis cases in Kerala, India. PLoS One 
2012;7:e46502. 
[13] Global Tuberculosis Report, 2012. Geneva: World Health Or-
ganization 2012.
[14] Young F, Critchley JA, Johnstone LK, et al. A review of co-mor-
bidity between infectious and chronic disease in Sub Saharan 
Africa: TB and diabetes mellitus, HIV and metabolic syndrome, 
and the impact of globalization. Global Health 2009;5:9.
[15] World Health Organization. Treatment of tuberculosis: guide-
lines for national program. Geneva: World Health Organization 
2006.
[16] The Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus. Report of the Expert Committee on the Di-
agnosis and Classification of Diabetes Mellitus. Diabetes Care 
1997;20:1183-97.
[17] World Health Organization. Tuberculosis and HIV data and 
statistics. www.who.int/hiv/topics/tb/data/en/index1.html
[18] Bekkee L-G, Wood R. The changing natural history of Tuber-
culosis and HIV coinfection in an urban area of Hyperendemic-
ity. Clin Infect Dis 2010;50:S208-S214. 
[19] Odaibo GN, Gboun MF, Ekanem EE, et al. HIV infection among 
patients with pulmonary tuberculosis in Nigeria. Afr Med J Sci 
2006;35:S93-8. 
[20] Mugusi F, Swai AB, Aberti KG, et al. Increased prevalence 
of diabetes mellitus in patients with pulmonary tuberculosis in 
Tanzania. Tubercle 1990;71:271-6.
[21] Ruslami R, Aarnoutse RE, Alisjahbana B, et al. Implications 
of the global increase of diabetes for tuberculosis control and 
patient care. Trop Med Int Health 2010;15:1289-99.
[22] Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L, et 
al. Association of diabetes and tuberculosis; impact on treat-
ment and post-treatment outcomes. Thorax doi:10.1136/tho-
raxjnl-2012-201756.
[23] Unadike BC, Eregie A, Ohwovoriole AE. Prevalence of hyper-
tension amongst patients with diabetes mellitus in Benin City, 
Nigeria. Niger J Clin Pract 2011;14:300-2. 
 ■ Received on April 6, 2014. Accepted on April 12, 2014.
 ■ Correspondence: Anthonia Ogbera, Department of Medicine, La-
gos State University Teaching Hospital Ikeja, Lagos Nigeria - E-
mail: oogbera@yahoo.co.uk.
